FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/10/075582 [Registered on: 21/10/2024] Trial Registered Prospectively
Last Modified On: 19/10/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Efficacy of Gudadi mandur vati will be check on iron deficiency anemia in pregnancy patients 
Scientific Title of Study   Randomized controlled clinical trial to evaluate the efficacy of Gudadi mandur in the management of garbhini pandu (iron deficiency anemia in pregnancy) 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Rutuja Ramchandra Yamgar 
Designation  PG Scholar 
Affiliation  C.S.M.S.S Ayurved Mahavidyalaya and Rugnalaya Kanchanwadi Aurangabad Maharashtra India 431001 
Address  OPD No 19 Prasuti Tantra and Streeroga Department C.S.M.S.S Ayurved Mahavidyalaya and Rugnalaya Kanchanwadi Aurangabad Maharashtra India 431011

Aurangabad
MAHARASHTRA
431011
India 
Phone  9922765463  
Fax    
Email  rutuja20yamgar@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Jayashri Shrikant Deshmukh 
Designation  Professor 
Affiliation  C.S.M.S.S Ayurved Mahavidyalaya and Rugnalaya Kanchanwadi Aurangabad Maharashtra India 431001 
Address  OPD No 19 Prasuti tantra and Streeroga Department C.S.M.S.S Ayurved Mahavidyalaya and Rugnalaya Kanchanwadi Aurangabad Maharashtra 431011 Maharashtra. 431011 India

Aurangabad
MAHARASHTRA
431011
India 
Phone  9325580777  
Fax    
Email  dr.jayashrisdeshmukh@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Rutuja Ramchandra Yamgar 
Designation  PG Scholar 
Affiliation  C.S.M.S.S Ayurved Mahavidyalaya and Rugnalaya Aurangabad Maharashtra India 431001 
Address  C.S.M.S.S Ayurved Mahavidyalaya and Rugnalaya Kanchanwadi Aurangabad Maharashtra India 431011

Aurangabad
MAHARASHTRA
431011
India 
Phone  9922765463  
Fax    
Email  rutuja20yamgar@gmail.com  
 
Source of Monetary or Material Support  
C.S.M.S.S. Ayurved Mahavidyalaya And Rugnalaya Kanchanwadi Aurangabad Maharashtra India 431001 
 
Primary Sponsor  
Name  C.S.M.S.S. Ayurved Mahavidyalaya and Rugnalaya Kanchanwadi Aurangabad Maharashtra India 431001 
Address  C.S.M.S.S. Ayurved Mahavidyalaya and Rugnalaya Kanchanwadi Aurangabad Maharashtra India 431001 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Rutuja Ramchandra Yamgar  C.S.M.S.S Ayurved Mahavidyalaya and Rugnalaya Kanchanwadi   OPD No.19 Prasuti tantra and Streeroga Department C.S.M.S.S Ayurved Mahavidyalaya and Rugnalaya Kanchanwadi Aurangabad
Aurangabad
MAHARASHTRA 
9922765463

rutuja20yamgar@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
CSMSS Ayurved Mahavidyalaya and Rugnalaya, Aurangabad  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:O990||Anemia complicating pregnancy, childbirth and the puerperium. Ayurveda Condition: PANDUROGAH, (2) ICD-10 Condition:O269||Pregnancy related conditions, unspecified. Ayurveda Condition: GARBINIROGAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmDrugClassical(1) Medicine Name: Dhatri lauha, Reference: Sharangdhar Samhita, Madhyam Khand, shlok no 7/2, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 500(mg), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 60 Days, anupAna/sahapAna: Yes(details: -Madhu), Additional Information: -
2Intervention ArmDrugClassical(1) Medicine Name: Gudadi Mandur , Reference: Bharat Bhaishajya Ratnakar, Dvitiya bhag, Gutikaprakranam, Page no 35/1310, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 500(mg), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 60 Days, anupAna/sahapAna: Yes(details: -Koshna Jal), Additional Information: -
 
Inclusion Criteria  
Age From  21.00 Year(s)
Age To  40.00 Year(s)
Gender  Female 
Details  1.Diagnosed Patients Of Garbhini Pandu
2.Pregnant Women Of 21 TO 40 Years Age.
3. Patients In Between 14 Weeks To 30 Weeks Of Preganancy.
4. Hb% Above 7gm% And Below 10 gm%. 
 
ExclusionCriteria 
Details  1. Patients Suffering From Severe Aenemia Hb Below 7 gm %.
2. Age Of Garbhini Below 21 Years And Above 40 Years.
3. Anemia Due To Major Disease , Known Case Of Thalassemia, Sickle Cell Anemia, Pernicious Anemia, Aplastic Anemia And Other Complications Like Bleeding Piles And Twin Pregnancy.
4.Any Other Obstetric Complication Like Pre-Eclampsia, Gestational Diabetes.
5. Patients With HbsAg , HIV, VDRL Positive.
6. Any Major Diseases that Interfere With The Corse Of Treatment. 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Alternation 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Hb % will increase  1 month 
 
Secondary Outcome  
Outcome  TimePoints 
Lakshanas of garbhini pandu will dicrease.  2 months 
 
Target Sample Size   Total Sample Size="92"
Sample Size from India="92" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   04/11/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Women are roota of progeny. Anemia is most commonest haematological disorder of pregnancy. During Garbhini Avastha increased fetal demands and improper functioning of Rasadhatu leads to Garbhini Pandu. Mother will not meet the extra demands of nutrients by diet alone. This lead to certain pathological condition in pregnant women. In addition, there is marked demand of extra iron during pregnancy specially in second half of pregnancy, even an adequate diet cannot provide the extra demand of iron. Thus, there is always remains a physiological iron deficiency state during pregnancy. 
                  The general principle of treatment that all the disease of pregnant women should be treated by drugs and diet which are predominantly Mrudu ( soft), Madhur ( sweet), Sheeta ( cold), Sukhakar( palatable) . All the diseases should be treated by Sanshaman Chikitsa. Gudadi Mandur is one of such drug.  Shunthi is Deepak, pachak and Raktashodhak. Pippali is Vrushya and Raktavardhak. Tila is Agnivardhak and Stanyajanak. Guda is Raktashodhak. Mandur Bhasma is considered as Raktavardhak. 
                  Study will be conducted on 92 diagnosed patients of Garbhini Pandu ( Iron Deficiency Anemia in Pregnancy) . written consent will be taken. Initial assessment will be done. patients treated with Gudadi Mandur in interventional group and with Dhatri Lauha in control group.patient will be assessed at follow up. Observation and result will be noted and statistical analysis will be done. Discussion and conclusion will be done. 

  •  Null hypothesis (Ho) - Gudadi Mandur is not effective in the management of Garbhini Pandu ( Anemia in Pregnancy)
  • Alternate hypothesis ( H1)- Gudadi Mandur is effective in the management of Garbhini Pandu ( Anemia in Pregnancy)
 
Close